Indeed, in contrast with the common agents that block the distal portion of the VEGF signaling pathway (17), PTC299 is a drug that block the production of tumor VEGF at the posttranscriptional level [Dr T. Davis, personal communication and (26)]. The gene discussed is VEGFA; the disease is neoplasm.